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Background and purpose — Aseptic loosening and infection are 2 
of the most common causes of revision of hip implants. Antibiotic 
prophylaxis reduces not only the rate of revision due to infection 
but also the rate of revision due to aseptic loosening. This suggests 
under-diagnosis of infections in patients with presumed aseptic 
loosening and indicates that current diagnostic tools are subopti-
mal. In a previous multicenter study on 176 patients undergoing 
revision of a total hip arthroplasty due to presumed aseptic loos-
ening, optimized diagnostics revealed that 4–13% of the patients 
had a low-grade infection. These infections were not treated as 
such, and in the current follow-up study the effect on mid- to long-
term implant survival was investigated.
Patients and methods — Patients were sent a 2-part question-
naire. Part A requested information about possible re-revisions of 
their total hip arthroplasty. Part B consisted of 3 patient-related 
outcome measure questionnaires (EQ5D, Oxford hip score, and 
visual analog scale for pain). Additional information was retrieved 
from the medical records. The group of patients found to have a 
low-grade infection was compared to those with aseptic loosening.
Results — 173 of 176 patients from the original study were 
included. In the follow-up time between the revision surgery and 
the current study (mean 7.5 years), 31 patients had died. No sta-
tistically significant difference in the number of re-revisions was 
found between the infection group (2 out of 21) and the aseptic 
loosening group (13 out of 152); nor was there any significant dif-
ference in the time to re-revision. Quality of life, function, and 
pain were similar between the groups, but only 99 (57%) of the 
patients returned part B. 
Interpretation — Under-diagnosis of low-grade infection in 
conjunction with presumed aseptic revision of total hip arthro-
plasty may not affect implant survival.

Aseptic loosening and infection are 2 common causes of revi-
sion in total hip arthroplasty (THA) (Sadoghi et al. 2013). 
Data from the Norwegian Arthroplasty Register and the 
Swedish Hip Arthroplasty Register have shown that antibiotic 
prophylaxis, administered either systemically, locally, or com-
bined, prevents infection and thus reduces revision rates due 
to infection. Interestingly, it has also been shown that the rates 
of revision due to aseptic loosening decrease with the use of 
antibiotic prophylaxis (Malchau et al. 2002, Engesaeter et al. 
2003). As theoretically the use of antibiotics should not have 
any influence on aseptic loosening, this suggests that the diag-
nosis of infection was inadequate. Under-diagnosis of infec-
tion in THA could possibly reduce the survival of revision hip 
implants. 
One of the major challenges when diagnosing low-grade 
infection is the accurate identification of microorganisms. 
These can be difficult to detect with routine diagnostics 
because of previous antimicrobial exposure or the require-
ment of certain microorganisms for specific nutrients, and 
also possibly due to reduced growth rates of biofilm-residing 
organisms (Fux et al. 2003, Schafer et al. 2008). To overcome 
this obstacle, new techniques for detection and identification 
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of bacteria have been introduced. For example, polymerase 
chain reaction (PCR) on bacterial 16S ribosomal RNA (rRNA) 
can theoretically detect as little as 1 bacterium in a sample 
(Trampuz et al. 2003, Clarke et al. 2004, Fenollar et al. 2006, 
Kobayashi  et al. 2009, Bergin  et al. 2010). The apparent dis-
advantage of this feature is that PCR detection is susceptible 
to bacterial contamination (Panousis et al. 2005).
Previously, our group developed and validated a combined 
16S rRNA PCR and reverse line blot hybridization (RLBH) 
technique, which could identify many bacteria at the spe-
cies level (Moojen et al. 2007). This combined technique 
was then used in a clinical study to test the hypothesis that 
there is under-diagnosis of infection in patients undergoing 
a THA revision due to aseptic loosening. In 7 Dutch hospi-
tals, 176 patients undergoing revision of their THA following 
a preoperative diagnosis of aseptic loosening were included. 
During surgery, tissue biopsies were obtained for microbio-
logical examination, pathological analysis, and broad-range 
16S rRNA PCR with RLBH. We showed that 7 (4%) of these 
patients had a bacterial infection and an additional 15 (9%) 
were suspected of having an infection. Of these 22 patients, 2 
were given a prolonged period of treatment with antibiotics. 
After a 1-year follow-up of 170 of the 176 patients, none of 
the 22 patients with an infection or suspected infection had 
undergone additional surgery. 
In the current study, we performed a mid- to long-term 
follow-up on this cohort to investigate the effects of missed 
low-grade infection on implant survival and clinical outcome. 
The hypothesis was that patients with an undiagnosed low-
grade infection would show a higher rate of implant failure 
and poorer clinical outcome.
Patients and methods
Study design
The initial multicenter prospective cohort study took place 
between November 2002 and July 2006 (Moojen et al. 
2010). During this period, 176 patients (127 women) with 
a preoperative diagnosis of aseptic loosening of their THA 
were admitted to one of the 7 Dutch hospitals participating 
in the study (Figure 1). The diagnosis was based on plain 
radiographs, ESR, and CRP levels. Furthermore, a large pro-
portion of the patients had an arthrocentesis performed or a 
radionuclide study. The patients were eligible for inclusion 
if they were at least 18 years of age and were scheduled for 
a 1-stage revision of the cup, stem, or both, after a preopera-
tive diagnosis of aseptic loosening. Both first revision cases 
and re-revision cases were included. Median age at the time 
of revision surgery was 72 (28–92) years. All patients were 
scheduled for a 1-stage revision and for a short course (1–5 
days) of prophylactic systemic antibiotics. The bacteriologi-
cal, histopathological, and PCR-RLBH results were analyzed 
postoperatively. Patients were regarded as infected when the 
results met the criteria as described by either Spangehl et al. 
(1998) or Atkins et al. (1999). In addition, the PCR-RLBH 
results were added to these criteria using the same criteria as 
for culture according to Atkins et al. (1999) or Spangehl et 
al. (1998). Since we wanted to analyze low-grade infections 
specifically, we adjusted the criteria for infection in order to 
be able to find patients suspected of being infected. A patient 
was suspected to have an infection when at least 2 culture 
results or 2 PCR-RLBH results were positive for the same 
microorganism, or if the pathological analysis showed a 
definitive positive result for infection. We found that 7 (4%) 
of these patients had a bacterial infection and an additional 
15 (9%) were suspected of having an infection. Of these 
22 patients with suspected infection, 2 were treated with a 
prolonged period of antibiotics after revision surgery, from 
which 1 received a 2-stage revision. After a 1-year follow-
up period in 170 of the 176 patients, none of the 22 patients 
with a (suspected) infection had received additional surgery 
(Moojen et al. 2010). 
With this patient cohort, the present follow-up study was 
performed to investigate whether an undiagnosed low-grade 
infection has any influence on the survival of the implant. 
For this purpose, we compared data between 2 groups: the 
group of patients with aseptic loosening (AL) and the group 
of patients with a (suspected) infection (INF). 1 patient was 
excluded from the current study because that patient received 
antibiotic treatment during the revision surgery. Between Sep-
tember 2012 and February 2013, data on implant survival and 
quality of life were collected using a 2-part questionnaire. 
When needed, additional information was obtained from the 
medical records. 
Figure 1. Study design. In the previous study, 176 patients with an 
aseptic loosening of their total hip prosthesis were included. After addi-
tional analysis, 22 patients were believed to have a low-grade infection. 
After a 1-year follow-up, no additional re-revisions were seen in those 
patients. The present study included 173 patients from the initial study.
THA revisions for
aseptic loosening
n = 176
1-year 
follow-up:
no rerevisions
Mid-/long-term
follow-up
(present study)
n = 173 included
Moojen et al., 
Acta Orthop 2010
True aseptic 
loosenings
n = 154
Low-grade
infections
n = 22
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Data acquisition
All information was handled confidentially, in accordance 
with the Dutch Personal Data Protection Act. Each patient was 
appointed a study identification number, according to which all 
data obtained were registered in a database. If possible in a rea-
soinable way, patients were asked for their informed consent. 
The patients received a 2-part questionnaire. Part A 
requested information about any possible additional revisions 
of their THA (e.g. if revised, and if so, the date and reason for 
revision). In part B of the questionnaire, quality of life was 
assessed using the EQ-5D, the Oxford hip score (OHS), and 
visual analog pain scale (VAS pain). 
Data analysis 
For comparison of the number of additional revisions between 
the AL and INF groups, Fisher’s exact test was used. Kaplan-
Meier analysis was used to create survival curves for the time 
from revision to re-revision of patients. The Tarone-Ware test 
was used to compare the survival probability between groups. 
Some data were non-informatively censored due to the death 
of patients without undergoing a re-revision. The EQ-5D 
results were transformed to index values using a standard-
ized descriptive protocol (Group 1990, Brooks 1996). OHS 
was assessed using the recommendations for ISIS outcomes 
(Dawson et al. 1996a, 1996b, Murray et al. 2007). EQ-5D 
index values and EQ-VAS scores, OHS outcomes, and the VAS 
pain scores of the groups with infection and without infection 
were compared using Student’s t-test. A normal distribution 
of the data was assumed, and Levene’s test revealed that there 
were no differences between variances. Any p-value of less 
than 0.05 was considered significant. All statistical analyses 
were performed using SPSS version 20.0.
Ethics
This study was reviewed and approved by the Medical 
Research Ethics Committee of the University Medical Center 
Utrecht (protocol number 12-214/C). 
Results
Demographics
Information about additional revisions was available for 173 
of the 176 patients (123 of 127 women) who were included in 
our initial study (152 from the AL group and 21 from the INF 
group) (Moojen et al. 2010). In addition to the patient who 
was excluded due to antibiotic treatment during the revision 
surgery, 2 patients declined to participate in the study. Of the 
patients excluded, 2 were from the AL group and 1 was from 
the INF group. All other patients gave informed consent. The 
mean age of the AL group was 77 (SD 12) years and that of 
the INF group was 77 (SD 9) years. Data on other potential 
confounding factors were not collected and were not taken 
into account. The mean duration of follow-up from revision 
surgery to the follow-up analysis was 7.6 (6.4–9.0) years. 
During this period, 31 people died (28 in the AL group and 
3 in the INF group). Due to small numbers in the group of 
patients diagnosed with infection (7) and the group of patients 
suspected of infection (15), both groups were taken together 
and used as 1 group in the analyses (INF). No significant dif-
ference was seen between the number of additional revisions 
in these groups (p = 0.5, Fisher’s exact test). 
Implant survival
Part A of the questionnaire was returned by 137 patients 
(79%). Of the remaining 36 patients, information about their 
re-revision (12) and/or death (24) was gathered from the medi-
cal records. In the AL and INF groups, 13 patients (9%) and 
2 patients (10%) underwent a re-revision of their THA. The 
95% confidence interval for the risk difference lay between 
−0.13 and 0.15. There was no significant difference between 
the number of additional revisions in these groups (p = 1.0). 
For the implant survival analysis (Figure 2), 29 patients (26 
AL and 3 INF patients, 17%) were missing from the analysis 
because the date of death was unknown and no information 
on possible re-revisions was available. None of the missing 
patients received a re-revision. For the 13 patients in the AL 
group who had undergone a re-revision by the end of the 
study, the estimated mean time until revision was 101 (SD 2) 
months. The 95% confidence interval (CI) of the mean values 
for survival time ranged between 97 and 106. The estimated 
mean time to revision for the 2 INF patients was 96 (SD 5) 
months, with a 95% CI of the mean values for survival time 
between 87 and 106. There was no significant difference 
between the survival curves of both groups (p = 0.9). 
Quality of life
Part B of the questionnaire was returned by 99 patients (57%). 
Of these forms, 85 were filled out completely and could be 
used for the EQ-5D; 94 could be used for both the OHS and 
VAS pain. 74 patients could not fill out the questionnaire 
1.00
0.97
0.94
0.91
0.88
0.85
Implant survival
80 120400
Months after index operation
Aseptic loosening
Low-grade infection
Figure 2. Kaplan-Meier survival curve showing the survival probability 
in the 2 groups of patients.
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because they were dead (31), lost to follow-up (8), or inca-
pable of filling out the questionnaire for medical reasons (6). 
In addition, 29 patients declined to fill out the questionnaire. 
In both groups, the patients showed a large variation in qual-
ity of life, functioning, and pain outcomes. Interestingly, no 
significant difference was found in health status as measured 
by the EQ-5D index values of the AL group (0.73 (SD 0.21)) 
and the INF group (0.73 (SD 0.16)). Furthermore, we found 
a similar spread in health as measured by the EQ-VAS (69 
(SD 20) vs. 69 (SD 17)). No significant difference in score 
for functioning and hip pain (as measured by the OHS) was 
observed for the AL patients (34 (SD 11)) and the INF patients 
(33 (SD 9) (p = 0.7). There was no significant difference in 
VAS pain between the AL patients (23 (SD 26)) and the INF 
patients (31 (SD 30)) (p = 0.3).
 
Discussion 
This follow-up study is the first to show that a missed low-
grade infection in patients diagnosed with aseptic loosening 
and receiving a revision THA does not appear to influence 
the mid- to long-term prognosis. The number of re-revisions 
and the survival time of the implant were similar between 
the patients with aseptic loosening and the patients with low-
grade infection. Quality of life, hip function, and pain were 
similar between the groups. These observations are in line 
with the findings of our previous study after 1 year of follow-
up (Moojen et al. 2010). 
Our study is unique, since until now there have been no 
studies investigating the influence of underdiagnosed low-
grade infections on the number of re-revisions or the survival 
time of orthopedic implants. To our knowledge, there have 
been no studies on the mid- to long-term effects of misdiag-
nosed low-grade infections on other types of implants. There 
are therefore no studies available for comparison. 
A limitation of the present study was the low sample size. 
Even though 176 patients were included in our initial study, 
only 2 events in the INF group could be included in the sur-
vival analysis. It is possible that we cannot prove any direct 
consequences of underdiagnosed low-grade infection of a 
THA, due to low numbers in this group. The risk of type-II 
error should be kept in mind when interpreting these data. 
This was also the case when the patients from the infected 
group and suspected group were combined. Another limitation 
is that it was only possible to measure cross-sectional quality 
of life, as quality of life was not assessed in our initial study 
(Moojen et al. 2010). Thus, we cannot draw any conclusions 
on the effect that under-diagnosis of infection has on quality 
of life over time. Furthermore, no reliable conclusions can be 
drawn from the results of the questionnaires due to the large 
proportion of missing cases and incomplete responses. 
Currently, there is no no gold standard available for micro-
biological diagnosis of infection. Commonly used criteria are 
those described by Spangehl et al. (1999) and Atkins et al. 
(1998). By using these criteria, it is possible to detect infec-
tions with satisfactory sensitivity and specificity. However, 
we have shown that in clinical practice low-grade infections 
are often missed (Moojen et al. 2010). One option to prevent 
under-diagnosis of infection is to lower the stringency of the 
criteria for the diagnosis, as this would increase sensitivity; 
however, it would also reduce the specificity. A more desirable 
option is to use techniques that can diagnose infection more 
reliably and sensitively in THA than those that are currently 
used. 
A successful treatment of implant-related infection in orth-
pedics relies on accurate diagnosis and correct identification 
of microorganisms and their possible resistances to antibiotics. 
Recently, different approaches for improvement of microbio-
logical diagnosis of infection have been explored. For exam-
ple, molecular techniques may help to detect and identify the 
possible presence of bacteria, but molecular biological proce-
dures must be performed with caution because of the risks of 
interfering contamination (Panousis et al. 2005, Fenollar et al. 
2006, Levy and Fenollar 2012). In our previous study (Moojen 
et al. 2010), we used PCR-RLBH in addition to standard diag-
nostics to test the hypothesis that there is under-diagnosis of 
infection in patients undergoing a THA revision due to aseptic 
loosening. That study showed that 4–13% of the 176 included 
patients with aseptic loosening of their THA probably suffered 
from an infection. This technique proved to be promising, but 
it is also associated with difficulties. For example, PCR can 
only detect the bacterial strains against which the primers are 
designed. Additionally, the high sensitivity of PCR results 
in a greater risk of contamination and thereby false positive 
results. Again, molecular techniques still lack the possibility 
of testing bacterial resistance. As a result of these limitations, 
few (if any) clinical laboratories have started to use PCR next 
to the standard microbiological culture techniques as part of 
the standard diagnosis. 
Another approach for improvement of microbiological 
diagnosis of infection is the sonication of explanted material 
(Trampuz et al. 2007). With this method, biofilm-residing bac-
teria are detached from the implant and can then be detected 
using standard culture methods. A recent meta-analysis on 12 
studies showed promising results of using sonication as an 
additional diagnostic tool to be able to culture biofilm-resid-
ing bacteria (Zhai et al. 2014). In addition, sonication can be 
combined with other techniques such as measuring microbial 
heat production or PCR-hybridization to potentially improve 
diagnosis of implant-related infection (Esteban et al. 2012, 
Borens et al. 2013).
Recently, it was shown that analysis of antimicrobial peptide 
expression in synovial fluids can provide valuable information 
for the diagnosis of periprosthetic infection (Gollwitzer et al. 
2013). Others have also found an increase in interleukins such 
as IL-1 and IL-6 in synovial fluid in periprosthetic joint infec-
tions (Paulsen et al. 2002, Deirmengian et al. 2005, 2010). 
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Moreover, researchers have found 5 biomarkers in synovial 
fluid that could indicate an infection with high sensitivity and 
high specificity (Deirmengian et al. 2014). These synovial 
fluid biomarkers may prove to be a valuable tool for the diag-
nosis of implant-related infections. However, clinical studies 
should be performed to provide more evidence. Furthermore, 
the efficacy of diagnosing low-grade infections remains elu-
sive. 
The issue of under-diagnosis of low-grade infection will 
remain a topic of debate until the current detection methods 
are improved, or until a new method is introduced with high 
sensitivity and specificity. Even then, the value of improved 
detection of low-grade infections will have to be established 
in clinical practice, as the results of the present study suggest 
that under-diagnosis of infection has no influence on either 
implant survival or quality of life.
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